Matthijs Glastra

CEO Matthijs Glastra sells 6,500 shares for $1,096,272.70 via scheduled 10b5-1 plan on 2026-06-02

Matthijs Glastra, CEO of Novanta Inc (NOVT), executed six separate sales totaling 6,500 shares for $1,096,272.70 on 2026-06-02, reducing his holdings from 42,761 to 36,261 shares (15.2% reduction). The transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on 2025-09-11, indicating this was a scheduled, non-discretionary execution rather than a timing-based decision. The blended average sale price was $168.66, compared to the current market price of $160.53, placing the transaction near the 52-week high ($171.85). Glastra's recent prior trades at NOVT (all in May 2026) showed 30-day returns ranging from +7.3% to +26.4%, though these outcomes are unrelated to the scheduled nature of the current filing.

CEO Matthijs sells 7,500 shares of NOVT for $1.1M; retains 42,761 shares post-sale

Matthijs Glastra, NOVANTA's Chief Executive Officer, sold 7,500 shares for $1,128,244.14 at a price of $155.71, currently -6.0% from the 52-week high and +20.8% over the past 30 days. The CEO retains substantial holdings of 42,761 shares post-transaction. This sale occurs under a pre-arranged 10b5-1 trading plan adopted on 2025-09-11, indicating a scheduled divestiture rather than a discretionary market-timing decision. The company shows solid financial performance with $257.7M in quarterly revenue and $21.1M in net income, though the P/E ratio of 105.93 reflects elevated valuation expectations.

NOVT CEO Glastra sells ~6,500 shares worth $852K, continuing a pattern of consistent sales with no recent buys.

CEO Matthijs Glastra has completed a multi-tranche sale totaling approximately $852,000 in NOVANTA stock, reducing his position across four separate transactions. This sale is notable because Glastra's insider track record consists entirely of sales—his twenty prior trades in this stock and elsewhere have all been exits, with no purchases on record. Most recently, he sold shares on multiple occasions in March and again in April, making this latest May sale part of an unbroken pattern of consistent selling activity. The underlying company is profitable with strong revenue growth, suggesting the sales are driven by portfolio management or liquidity strategy rather than fundamental deterioration. However, the complete absence of buying activity, even as the company posts healthy fundamentals, underscores a consistent conviction to reduce exposure that investors may find worth monitoring, particularly given Glastra's prominent role as CEO.

CEO Glastra sold 6,500 NOVT shares at $130.05; recent same-ticker sells all showed 30d declines of -12.1% to -15.7%

Glastra Matthijs, Chief Executive Officer, sold 6,500 shares at $130.05, reducing holdings by -10.3% to 56,761 shares. His prior five sales at NOVT on 2026-03-02 all showed 30-day declines ranging from -12.1% to -15.7%, establishing a consistent same-ticker pattern of immediate post-sale price erosion. The current stock price of $132.40 is -9.6% from the 52-week high of $146.39, and the 30-day change of +16.3% reflects a recent recovery from those earlier sell-offs. The P/E ratio of 111.26 is notably elevated relative to fundamentals (quarterly revenue $247.8M, net income $10.7M), suggesting the stock may be pricing in significant forward expectations. The cluster of sales within a compressed timeframe on 2026-03-02 followed by this April sale warrants attention to whether the CEO perceives valuation constraints or other operational considerations.

CEO Glastra sells 6,500 shares across 8 transactions for $899,239.12 at NOVT on 2026-03-02

Glastra Matthijs, Chief Executive Officer of NOVANTA INC, executed 8 separate sales on 2026-03-02 totaling 6,500 shares for $899,239.12, reducing his holdings by 9.3% to 63,261 shares. The multiple tranches sold at prices ranging from $131.92 to $140.48, with a blended average price of $138.34, which is 1.6% below the current price of $140.64 and 3.9% below the 52-week high of $146.39. NOVT's stock has appreciated 4.7% over the past 30 days and 19.8% over 90 days, reflecting positive recent momentum. Across his open-market trading history on all tickers, the CEO's 20 prior sells averaged -0.1% 30-day return and -5.2% 90-day return, with a 61.54% well-timed rate; however, his 5 prior trades at NOVT show 4 measurable 30-day outcomes (all positive: +2.4% to +4.6%) and 0 measurable 90-day outcomes on this specific ticker.

CEO Glastra sells 7,500 NOVT shares for $1.1M at $145.04; 8 sales in 10 days suggest planned liquidation.

Glastra Matthijs, CEO of Novanta, sold 7,500 shares on 2026-02-10 at $145.04, bringing his holdings from 64,867 shares to 57,367 shares and reducing his stake by 11.6%. This sale is part of a concentrated liquidation pattern: same-ticker history shows 5 prior trades at NOVT, including four separate sales on 2026-02-02 (just 8 days prior), followed by this sale 8 days later. The sales cluster is noteworthy given the CEO's substantial remaining position of 57.4K shares and the stock's strong recent performance (+34.2% over 90 days, +6.0% over 30 days), placing the current price at $139.29 only 6.7% below the 52-week high of $149.30. While the company carries a premium valuation (P/E of 94.11) and modest profitability ($10.7M net income on $247.8M revenue), the pattern of frequent open-market sales within days—rather than scheduled or formulaic transactions—merits tracking to assess whether this reflects a shift in the CEO's conviction regarding near-term value or simply personal capital reallocation.

NOVT CEO Matthijs sells 6,500 shares for $878.5K; all 3 prior NOVT sales showed 90-day declines (-6.9% to -19.4%)

Glastra Matthijs, Chief Executive Officer, executed 4 separate sales totaling 6,500 shares for $878,458.68 on 2026-02-02, reducing his holdings by 9.1% to 64,867 shares. The pattern of timing is notable: his 3 prior measurable sales at NOVT (all on 2024-11-11) preceded 90-day declines ranging from -6.9% to -19.4%, establishing a 100% well-timed sell rate at this ticker. Stock price has risen +27.5% over 90 days and is currently -8.6% from its 52-week high, creating a backdrop of recent strength. The recency of recent sales (2026-01-21 and 2026-01-09) combined with this new filing suggests ongoing liquidation activity, though cross-ticker track record shows modest 90-day underperformance (-2.2% average) with a 44.44% well-timed rate—neither conclusive.

CEO Glastra Matthijs sold 7,500 shares of NOVT at $140.00 on 2026-01-21; stock has declined 8.8% from 52-week high, prior NOVT sales all negative at 90-day mark.

Glastra Matthijs, CEO of NOVANTA INC, sold 7,500 shares for $1,050,000.00, reducing holdings from 78,867 to 71,367 shares. The sale occurred at $140.00, below the 52-week high of $151.20 and above the current price of $137.89 (now 8.8% from the high). Notably, Glastra's prior trades at NOVT show a consistent pattern: all 4 measurable sales at this ticker posted negative 90-day returns, ranging from -6.4% to -20.1%, indicating each preceded subsequent stock declines. His cross-ticker track record reveals a 42.11% well-timed rate on 20 prior sells with average 90-day returns of -1.5%, suggesting a demonstrated ability to sell before weakness. The current transaction, following a +12.4% gain over the prior 30 days and a recent January 9 sell, warrants attention as part of a pattern of sales at or near intermediate peaks before subsequent pullbacks.

CEO Matthijs sold 6,177 shares of NOVT at $130.00 for $803,010.00; extends pattern of well-timed sales at this ticker (5 of 5 prior trades achieved negative 90-day returns)

Glastra Matthijs, Chief Executive Officer of Novanta Inc, sold 6,177 shares at $130.00 on 2026-01-09, reducing holdings from 85,044 to 78,867 shares. This sale is notably consistent with the CEO's prior track record at this ticker: all 5 prior sales at NOVT (executed on 2024-11-11) achieved negative 90-day returns ranging from -6.4% to -20.1%, representing a 100% well-timed rate at the same ticker. His broader cross-ticker history shows a 42.11% well-timed rate across 19 prior sales with an average 90-day return of -1.5%. The current stock price of $131.47 represents a +10.5% gain over 30 days and +24.4% over 90 days from the transaction date, suggesting this sale predated recent upward momentum. The company's valuation metrics show a P/E of 88.83 against $247.8M in latest-quarter revenue and $10.7M net income, which investors should evaluate relative to the CEO's apparent conviction in reducing exposure.

CEO Glastra sells 7,500 shares at blended avg $179.70; stock now $170.17, down 8.6% from 52-week high.

Matthijs Glastra, Chief Executive Officer of Novanta Inc, executed 5 separate sales totaling 7,500 shares for $1,347,785.51 on 2024-11-11 at prices ranging from $178.36 to $183.16, near the upper end of the 52-week range ($121.37–$186.20). His post-transaction holding of 56,382 shares represents an 11.7% reduction from his prior 63,882 shares. The current price of $170.17 is 8.6% below the 52-week high and reflects a 3.6% decline over the past 30 days. Notably, Glastra's prior 5 sales at NOVT (July 2024 and April 2024) show poor timing at the 90-day mark, with only 1 of 5 characterized as well-timed; his July sales coincided with stock gains of 8.2% to 11.8% over 90 days, indicating he sold ahead of rallies. The company's valuation metrics are stretched (P/E of 101.90) relative to modest FY revenue growth of 2.4%, though recent quarterly net income of $19.2M on revenue of $244.4M shows operational stability. The timing of this sale, executed near recent highs ahead of a documented price decline, warrants observation of whether it reflects broader caution about near-term momentum or is part of a recurring pre-planned disposition pattern.